Employees of the Month: Urvashi Rai and Alyssa Arnheim

The Sanaria employee of the month for February, 2021 are Urvashi Rai and Alyssa Arnheim. Urvashi is a member of the Vaccine Extraction and Model Systems team and was nominated for employee of the month for her support of the Quality Control team. Alyssa is a member of the Vaccine Extraction and Immunology Model Systems team and was nominated for employee of the month for her support of company operations during the pandemic.

EUMF Investment of €12.9M in Sanaria Highlighted in BioBuzz Article

On December 2nd, 2020, the European Union Malaria Fund’s (EUMF) investment of €12.9 million in Sanaria Inc. was highlighted in an BioBuzz article written by Alex Keown.

The investment will fund the development of two Malaria vaccines, one Malaria prophylactic, and a SARS-CoV-2 vaccine. Sanaria is the first and only U.S.-based company that has received funding from the EUMF!

The full article can be accessed by this link.|

Sanaria and Protein Potential Host Shari Davis Who Facilitated a Discussion: Let’s Talk About Race & Racism

In an effort to support the end of, and continue the discussion about systemic racism, Sanaria Inc. and Protein Potential, LLC hosted Ms. Shari Davis, ACC, SPHR, SHRM-SCP, President and CEO of Venture HCM LLC. Ms. Davis gave a presentation to and facilitated a discussion with our staff about the Black Lives Matter movement.

Contact Us


We welcome your feedback and inquiries. Please be in touch.

Address:

Sanaria Inc.
9610 Medical Center Drive, Suite 200
Rockville, MD 20850

Phone:

+1.301.770.3222

Social: